COMP <GO>
PLX vs DTIL // OPERATING MARGIN
Protalix BioTherapeutics Inc. (NYSE) VS. Precision BioSciences Inc. (NASDAQ) • 15-METRIC TALLY: PLX 6
— DTIL 1
▲ OPERATING MARGIN LEADER: PLX
LAST: $2.59 (-0.77%) • MKT CAP: $210.3M
operating-margins
-10.40%
LAST: $7.06 (-5.11%) • MKT CAP: $205.4M
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLX VS. DTIL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PLX | DTIL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.00% | -35.00% | +22.00 | PLX | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -6.48% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | -10.40% | -60.00% | +49.60 | PLX | /operating-margins <GO> |
| Net Profit Margin | -12.50% | -60.00% | +47.50 | PLX | /net-margins <GO> |
| Revenue Growth (YoY) | -1.20% | -50.10% | +48.90 | PLX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 0.20 | 0.00 | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 1/9 | +1.00 | PLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.3 | 55.8 | -8.51 | DTIL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $210.3M | $205.4M | $4.9M | PLX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PLX REV | DTIL REV | PLX GROSS % | DTIL GROSS % | PLX FCF | DTIL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $52.7M | $34.3M | 48.8% | — | -$13.6M | -$65.8M |
| FY 2024 | $53.4M | $68.7M | 54.5% | — | $7.4M | -$58.4M |
| FY 2023 | $65.5M | $48.7M | — | — | -$1.3M | -$84.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLX // BETA —
DTIL // BETA —